SHREVEPORT – U.S. Senator Bill Cassidy, M.D. (R-LA) today visited the facility on Line Avenue in Shreveport that was once owned by Dr. Reddy’s Laboratories. He spoke with officials from the North Louisiana Economic Partnership (NLEP) and Louisiana Economic Development (LED) on what they’re doing to find new ownership for the facility, so medicine can again be produced there.
“President Trump is doing his best to make the United States a place where businesses invest in,” said Dr. Cassidy. “We need increased domestic manufacturing of drugs. I’m committed to the economic development of Northwest Louisiana, and bringing in full production facilities for drugs and other goods.”
Cassidy’s visit comes on the heels of a major announcement by the White House of an $11 billion boost by Gilead Sciences to its domestic operations. During President Trump’s second term, eight other pharmaceutical companies have made multi-billion dollar investments in domestic manufacturing, according to a White House press release issued yesterday.
According to NLEP, the Dr. Reddy’s site can produce up to 4 billion tablets per year. Cassidy was met by Mr. Justyn Dixon, President and CEO of NLEP.
“Senator Cassidy has long been a champion for North Louisiana, and we deeply appreciate all he has done – and continues to do – for our region,” said Mr. Dixon. “With the growing number of pharmaceutical companies announcing plans to reshore or expand manufacturing operations, we believe the Dr. Reddy’s site provides these companies the ideal speed to market opportunity. We appreciate the Senator taking the time to visit and engage directly to gain a deeper understanding of this valuable outlet.”
Additionally, Cassidy joined the President last week for an “Invest in America” event, where Trump thanked Cassidy for his support. Under President Trump’s leadership, key investments have been made in Louisiana, including a $5.8 billion investment by Hyundai Steel which will create 1,500 jobs, and an $18 billion investment by Venture Global and $17.5 billion investment by Woodside Energy for liquefied natural gas.
###